Hedge fund managers are riding their best stock ideas as long as possible and but overall returns continue to lag.» Read More
General Mills said Thursday quarterly profit rose 8.9%, helped by higher sales and profit margin expansion.
There are two kinds of companies in the market – cyclical and secular. One of the most important moves in the game is to know when to shift your money from one to the other. Luckily, Cramer knows the precise moment.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
"Mad Money's" Jim Cramer takes a look at the contest is this video segment from Friday night's "How To Win" program. He does a lot of work to come up with some interesting picks! (we'll give you one without watching--General Mills).
Fresh data about the weak-kneed housing market and a two-day Fed meeting are highlights in a week that investors enter with anxiety.
Remember last week when Cramer told you to wait on financials until they all reported? Well, they have. Here’s how to play them and more next week.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Cramer reiterates his stance on Big Pharma, and tells callers whether to buy or sell Gateway, Titanium Metals and more...
For the first Lightning Round of the Cramer's third year, he fires off advice on Disney, Ameriprise, Walgreen and more...
Your best bets in biotech, drilling and more...
After the trauma of a 416-point drop in the market, Cramer likes to go fishing – bottom fishing, actually. He has 25 years of experience angling through the wrecks of portfolios that belonged to less experienced fisherman and women, and today he’s going to share his secrets with you.
Campbell Soup posted better-than-expected quarterly profit this morning, sending its shares to a seven-year high, as sales of Pepperidge Farm baked goods offset U.S. soup sales that fell amid unseasonably warm weather during much of the quarter.
Roche reported today that it sold $2.1 billion worth of Tamiflu last year (a 68% increase). Tamiflu is the antiviral that you take shortly after you feel like you've got the flu or as a prophylactic if someone literally close to you has it. But the main driver behind the sales spike last year was government stockpiling of the drug in case of a pandemic.
When Pfizer announced its deeper cost cuts last week, including a total of about 10,000 layoffs, analysts said other big drug companies that had not already started restructuring would use the industry giant as the model. Sure enough, today AstraZeneca said it will get rid of 3,000 employees (5% of its workforce) over the next few years. Also: Gilead shares at record high.
Shares of Gilead Sciences jumped to an all-time high on Thursday after the biotechnology company said 2007 sales would rise as much as 35% and analysts raised their price targets on the shares.
Some 270 people have contracted the H5N1 virus or avian flu, according to the World Health Organization, and 164 of them have died. It's the high death rate--greater than 50%--that has alarmed so many health officials. One drug that is on the market for patients is Tamiflu--made by Gildead Sciences. Sales of the drug have made a big turnaround over the last few years...
Sellers outnumbered buyers on Wall Street after multiple reports signaled a slowdown in economic growth. CNBC's "Closing Bell" team sorted through the details.
All the major market indexes finished lower for the day. Volume is likely to be light on Friday ahead of the Christmas holiday.
Packaged food company General Mills on Thursday reported higher quarterly earnings, helped by increasedsales across all business segments and improved margins.
I must say I continue to be very impressed with the way Spalding is handling this NBA ball recall thing. Talk about taking the high road. This afternoon, I checked out the Spalding Web site to see this...
Today is World AIDS Day--and it comes at a time when health experts are considering new strategies in an attempt to change the environment of AIDS transmission. The rate of H-I-V infection is growing, with more than four million new cases each year. One biopharmaceutical company whose portfolio includes several HIV treatments--is Gilead Sciences.